Limited options, high costs, and a lack of novel ideas have long hindered the treatment of rare genetic disorders. Existing therapies may manage symptoms for millions of patients worldwide, but often fall short regarding long-lasting changes. Lingyi Biotech is a clinical-stage biotechnology company that's taking a different approach.

With full mobile penetration and low churn rates in the US, there's simply no business case for the major operators to do better. Enter Pronto Mobile with a completely different approach.

Aurmor.ai is defining a new category in youth sports brain injury prevention and recovery. The company has pioneered the concept of Cumulative Neural Load (CNL), a framework for identifying, measuring, and mitigating the accumulation of repeated Motion-Induced Brain Stress (MiBS) during athletic activity.

While the promise of blockchain technology and decentralized finance is driving unprecedented innovation, the path to mass adoption is anything but straightforward. Five primary challenges are shaping the landscape for issuers, investors, and regulators alike.

Surgeons often struggle to confirm adequate blood flow in vessels and tissue during 100 million procedures annually (out of 450 million total). Thanks to bold, quantum-inspired biosensing from the founder's work at UF's Quantum Theory Project, Viewflow enables surgeons to point and visualize blood flow as augmented reality anytime during open surgery.

Alpha Watt, a vital contributor to the Upper Peninsula's (UP) economic growth through its bitcoin mining data center in Dafter, is addressing the damaging actions of Indivisible, a billionaire-funded activist group reportedly backed by George Soros.

As global markets evolve, a select group of leaders is not only adapting but actively shaping what comes next. Dennis Tomala is one of those rare individuals. As founder of HYGH Capital, Tomala has emerged as a pioneering voice in the fusion of traditional investment strategy and blockchain innovation.

Many current heart failure monitoring methods are ineffective, costly, and inaccessible to much of the population (particularly in the US). BodiGuide, led by CEO Deborah Kessler, has created a way to change the game in heart failure management.

While most entertainment companies treat fans as passive consumers, Evil Genius believes it's time to put the power in their hands. With a unique dual-engine model and a bold vision for participatory storytelling, the company is building what it calls the "Roblox for storytelling IP."

We spoke with Sophia Kleshchuk, a seasoned expert in product development and investor relations, about why today's space and defense startups need a tailored IR and communications strategy to stand out.